Stanford University: Leukemia, Myeloid, Acute trials
The registry lists 17 Leukemia, Myeloid, Acute studies with Stanford University as lead sponsor. 5 are open to participants now and 4 have results posted.
Phase 1 8Phase 2 8Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell TransplantNot yet recruitingNCT07634536Phase 2
- TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTRecruitingNCT07302776Phase 1
- Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AMLRecruitingNCT06561152Phase 1/2
- Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCTRecruitingNCT06551584Phase 1
- Niclosamide in Pediatric Patients With Relapsed and Refractory AMLRecruitingNCT05188170Phase 1
- Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T CellCompletedNCT01660607Phase 1/2Results posted
- Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDSTerminatedNCT01442714Phase 2Results posted
- Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)CompletedNCT00890929Phase 1/2Results posted
- Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AMLTerminatedNCT00568633Phase 3Results posted
- Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid LeukemiaCompletedNCT04885127Not applicable
- Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid LeukemiaCompletedNCT02856204
- Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCTTerminatedNCT02728700Phase 1
- Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-TransplantWithdrawnNCT02723435Phase 2
- Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT01904643Phase 1
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWithdrawnNCT01835288Phase 2
- Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent RemissionCompletedNCT00186381Phase 2
- Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)TerminatedNCT00185523